EMA 2025 Annual Report Annexes: Committees, Opinions, and Governance
The document comprises 24 annexes documenting EMA committee memberships, 2025 scientific opinions, and regulatory decisions across human and…
Critical impact 374 min
Drug profile · INN
emb- is an FDA-listed pharmaceutical active ingredient.
emb- is an FDA-listed pharmaceutical active ingredient.
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
emb- is an FDA-listed pharmaceutical active ingredient.